Control of estrogen binding protein concentration under basal conditions and after estrogen administration.
D000818:Animals; D002247:Carbon Isotopes; D002458:Cell Fractionation; D002467:Cell Nucleus / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D002850:Chromatography, Gel; D003513:Cycloheximide / Q000494:pharmacology; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D004958:Estradiol / Q000008:administration & dosage / Q000378:metabolism*; D005260:Female; D006207:Half-Life; D007930:Leucine / Q000378:metabolism; D011485:Protein Binding; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D011955:Receptors, Drug; D013268:Stimulation, Chemical; D013395:Sucrose; D013997:Time Factors; D014316:Tritium; D014599:Uterus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000502:physiology
D002247:Carbon Isotopes; D011955:Receptors, Drug; D014316:Tritium; D003609:Dactinomycin; D004958:Estradiol; D013395:Sucrose; D012313:RNA; D003513:Cycloheximide; D007930:Leucine